FindTrial
Sign In

Research for the role of circRNA in type 2 diabetes and LADA: a case-control study

Research for the role of circRNA in type 2 diabetes and LADA: a case-control study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020644
Enrollment
Unknown
Registered
2019-01-11
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

T2DM group:N/A
LADA group:N/A
healthy control group:N/A

Sponsors

Second Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 55 Years

Inclusion criteria

Inclusion criteria: Case Group:Confirmed type 2 diabetes or LADA aged 30 to 55. Control Group: Healthy people aged 30 to 55.

Exclusion criteria

Exclusion criteria: the patients with diabetes complications.

Design outcomes

Primary

MeasureTime frame
blood glucose;blood lipid;liver function;kidney function;pancreas islets function;insulin autoantibody(IAA);Islet Cell Antibody(ICA);glutamic acid decarboxylase antibody(GADA);protein tyrosine phosphatase antibody(IA-2A);Glycated hemoglobin;—

Secondary

MeasureTime frame
Height;Weight;Age;Sex;Family History;—

Countries

China

Contacts

Public ContactHanqing Cai

Second Hospital of Jilin University

caihanqing16@163.com+86 13674315020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026